Switch to Aim helps Frontier cut losses
In its maiden results since being split from Sigma Capital in January, Aim-quoted Frontier yesterday revealed that its loss before tax had been reduced to £269,000 in the year to 30 June from £326,000.
Revenues from services rose to £158,000 from £142,000, with a £149,000 revaluation of its assets pushing total turnover up to £307,000 from the previous year’s £94,000. That period had been affected by a write-down.
Advertisement
Hide AdAdvertisement
Hide AdHouse broker Arbuthnot expects the company to break even in its current financial year as the value of its investments rises. Frontier executive chairman Neil Crabb told The Scotsman: “I’m pleased with the increase in activity since the start of the financial year and we’re exploring opportunities with a number of other potential partners.”
The firm switched from the Plus stock market to Aim in January, raising £1 million. In May, it signed a deal to help Plymouth University commercialise its research, building on existing agreements with Dundee University and Aberdeen’s Robert Gordon University.
Crabb also revealed that it had added two spin-outs from Dundee University to its portfolio: Glycobiochem, which makes software for modelling chemicals and produces chemical ingredients; and Kinetic Discovery, a drug-discovery firm that also offers services to third parties.